FindTrial
Sign In

A study comparing quality of life and side effects in participant with epilepsy who respond well to medicines and those who do not.

Comparison of Quality of Life and Adverse events among Drug Refractory and Drug Sensitive persons with Epilepsy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/109417
Enrollment
20
Registered
2026-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G409- Epilepsy, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

AIIMS, New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age equals to 18 years and above 2 diagnosed with drug resistant epilepsy and drug sensitive epilepsy on the basis of ILAE criterion. 3 Subjects willing to Participate and able to provide written informed consent 4 Subjects with basic understanding of Hindi or English

Exclusion criteria

Exclusion criteria: 1 Alcohol Consumption 2 Preganant and lactating women 3 History of other chronic communicable / non communicable medical illness. 4 patients diagnosed with other neurological/ psychiatric conditions and are on treatment for the same.

Design outcomes

Primary

MeasureTime frame
1 QOLIE-31 score 2 PHQ-9 score 3 LAEP score 4 NDDI-E scoreTimepoint: at baseline—

Secondary

MeasureTime frame
1 To assess quality of life scores using the QOLIE-31 scale. 2 To assess the severity of depressive symptoms using the NDDI-E and PHQ-9 scales. 3 To evaluate the burden of treatment-related adverse effects using the LAEP scale. Timepoint: 8 MONTHS—

Countries

India

Contacts

Public ContactHiba Zulfuqar

All India Institute of Medical Sciences, New Delhi-110029

jatinderkatyal.aiims@gmail.com01126593282

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026